Search results
FDA advises vaccine manufacturers to make COVID-19 booster targeting KP.2 strain
ABC Action News Tampa Bay· 11 hours agoThe FDA has issued an updated recommendation for the fall COVID-19 vaccine formula. "Coverage in the...
Kansas attorney general sues Pfizer over marketing of COVID-19 vaccine
The Day· 7 days agoKansas Attorney General Kris Kobach is suing the pharmaceutical company Pfizer, alleging it...
Kansas AG joins with Texas to become second state to sue Pfizer over COVID-19 vaccine
BizPac Review· 6 days agoKansas Attorney General Kris Kobach announced on Monday that he was suing the pharmaceutical company Pfizer over the COVID-19 vaccine ...
COVID summer wave grows, especially in West, with new variant LB.1 on the rise
CBS News· 3 days agoA summertime wave of COVID-19 infections is arriving earlier than last year across a growing share...
Pfizer CEO’s COVID-19 ‘rehearsal’ comment out of context
Politifact· 2 days agoA Threads post took a year-old statement by Pfizer CEO Albert Bourla out of context to say the...
Column: This GOP-leaning political polling firm has turned into a purveyor of anti-vaccine...
Los Angeles Times· 6 days agoNot only have its results become more sharply partisan, favoring Republican and conservative...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 4 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
Biden admin seeks to delay releasing data on COVID vaccine reactions, report says
NBC Montana· 4 days agoThe Biden administration on Tuesday asked for a delay in releasing data on reactions to COVID-19 ...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 3 days agoNovavax shares aren't forming a chart pattern. The Sanofi deal is a positive for Novavax and could...
Grace Hills, Kansas Reflector
The Raw Story· 7 days agoThe state seeks “civil monetary penalties, damages, and injunctive relief from misleading and deceptive statements made in marketing its COVID-19 vaccine
